U-Neuron Biomedical (ROCO:6973) OCF Margin %: -18.93% (As of Dec. 2025)


ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$33.75
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical OCF Margin %?

U-Neuron Biomedical ROCO:6973 12 OCF Margin % is -18.93% as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, U-Neuron Biomedical ranks better than 52.32% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. U-Neuron Biomedical's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$-8.06 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2025 was NT$42.58 Mil. Therefore, U-Neuron Biomedical's OCF Margin % for the quarter that ended in Dec. 2025 was -18.93%.

As of today, U-Neuron Biomedical's current OCF Yield % is -3.18%.

The historical rank and industry rank for U-Neuron Biomedical's OCF Margin % or its related term are showing as below:

ROCO:6973' s OCF Margin % Range Over the Past 10 Years
Min: -196.89   Med: -116.68   Max: -2.3
Current: -50.04

During the past 6 years, the highest OCF Margin % of U-Neuron Biomedical was -2.30%. The lowest was -196.89%. And the median was -116.68%.

ROCO:6973's OCF Margin % is ranked better than
52.32% of 950 companies
in the Biotechnology industry
Industry Median: -65.71 vs ROCO:6973: -50.04

U-Neuron Biomedical OCF Margin % Related Terms

U-Neuron Biomedical OCF Margin % Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical OCF Margin % Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -2.30 -135.69 -196.89 -116.68 -50.04

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -121.41 -172.73 -70.80 -83.07 -18.93

ROCO:6973 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, U-Neuron Biomedical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's OCF Margin % falls into.


ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-41.361/82.663
=-50.04 %

U-Neuron Biomedical's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-8.062/42.579
=-18.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -18.93% mean?
U-Neuron Biomedical (ROCO:6973) has a OCF Margin % of -18.93% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on U-Neuron Biomedical and its competitors. According to the industry distribution chart, U-Neuron Biomedical ranks #453 out of 950 companies in the Biotechnology industry, placing it in the top 47.7%.
Is U-Neuron Biomedical's OCF Margin % too high?
U-Neuron Biomedical's current OCF Margin % is -18.93%. Based on the distribution chart, U-Neuron Biomedical ranks #453 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, U-Neuron Biomedical ranks #453 out of 950 companies for OCF Margin %. This puts U-Neuron Biomedical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current OCF Margin % is -18.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current OCF Margin % of -18.93%. The current OCF Margin % is -18.93%. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current OCF Margin % is -18.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.75
Price